Trevi
Trevi is a Connecticut-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic neurologically mediated conditions.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Trevi Information
Geographic Data
Address: 195 Church Street
City: New Haven
State: CT
Zip: 06510
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$55M
Raised Total:$157M
Social
Metrics
3,148,995Website Global Rank
5,188Website Monthly Traffic
Twitter Followers
Description
Trevi is a Connecticut-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic neurologically mediated conditions.
Contact Phone:
+12033042499
Contact Email:
Trevi went public on 5/7/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/7/2019
IPO Valuation:
$177M
Ticker Symbol:
TRVI
IPO Price:
$10/share
Amount Raised:
$55M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
